MAPK signaling is necessary for neurogenesis in Nematostella vectensis by Michael J. Layden et al.
RESEARCH ARTICLE Open Access
MAPK signaling is necessary for
neurogenesis in Nematostella vectensis
Michael J. Layden1*, Hereroa Johnston3, Aldine R. Amiel3, Jamie Havrilak1, Bailey Steinworth2, Taylor Chock2,
Eric Röttinger3 and Mark Q. Martindale2*
Abstract
Background: The nerve net of Nematostella is generated using a conserved cascade of neurogenic transcription
factors. For example, NvashA, a homolog of the achaete-scute family of basic helix-loop-helix transcription factors, is
necessary and sufficient to specify a subset of embryonic neurons. However, positive regulators required for the
expression of neurogenic transcription factors remain poorly understood.
Results: We show that treatment with the MEK/MAPK inhibitor U0126 severely reduces the expression of known
neurogenic genes, Nvath-like, NvsoxB(2), and NvashA, and known markers of differentiated neurons, suggesting that
MAPK signaling is necessary for neural development. Interestingly, ectopic NvashA fails to rescue the expression of
neural markers in U0126-treated animals. Double fluorescence in situ hybridization and transgenic analysis
confirmed that NvashA targets represent both unique and overlapping populations of neurons. Finally, we used a
genome-wide microarray to identify additional patterning genes downstream of MAPK that might contribute to
neurogenesis. We identified 18 likely neural transcription factors, and surprisingly identified ~40 signaling genes
and transcription factors that are expressed in either the aboral domain or animal pole that gives rise to the
endomesoderm at late blastula stages.
Conclusions: Together, our data suggest that MAPK is a key early regulator of neurogenesis, and that it is likely
required at multiple steps. Initially, MAPK promotes neurogenesis by positively regulating expression of NvsoxB(2),
Nvath-like, and NvashA. However, we also found that MAPK is necessary for the activity of the neurogenic
transcription factor NvashA. Our forward molecular approach provided insight about the mechanisms of
embryonic neurogenesis. For instance, NvashA suppression of Nvath-like suggests that inhibition of progenitor
identity is an active process in newly born neurons, and we show that downstream targets of NvashA reflect
multiple neural subtypes rather than a uniform neural fate. Lastly, analysis of the MAPK targets in the early
embryo suggests that MAPK signaling is critical not only to neurogenesis, but also endomesoderm formation
and aboral patterning.
Background
Cnidarians (e.g., corals, sea anemones, and “jellyfish”)
are the closest group of animals to the Bilateria (all bilat-
erally symmetrical animals such as vertebrates, flies, and
nematodes), and are thus an important taxon to under-
stand the origin and evolution of complex traits such as
nervous systems [1]. Nematostella vectensis is a proven
cnidarian model because it is easy to maintain in
laboratory culture, its genome is sequenced and anno-
tated, and multiple tools exist for functional genetic
approaches [1–6].
The Nematostella nervous system comprises endoder-
mal and ectodermal nerve nets [7, 8]. Neuronal cell bodies
are arranged in a “salt-and-pepper pattern” such that indi-
vidual neurons are scattered amongst non-neural cell
types. Differentiating neurons are first detected in the late
blastula stage before invagination of the presumptive
endodermal plate [7, 9]. Salt-and-pepper expression of
both NvsoxB(2) and Nvath-like (also called Nvarp3) are
the earliest known neurally expressed genes and they
define proliferative neural progenitor cells [9, 10]. Shortly
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after Nvath-like and NvsoxB(2) are detected, expression of
post mitotic neural markers such as NvashA and Nvelav1
is detected [7–9, 11]. Nvelav1 is broadly expressed in a
large number of neurons, though it is still unclear if it is a
pan-neuronal marker in Nematostella [8]. Morpholino
(MO)-mediated knockdown of either NvsoxB(2) or Nvath-
like results in a loss of expression of both Nvelav1 and the
neural subtype marker NvashA [9, 10]. NvashA is
expressed in a smaller number of developing neurons at
embryonic stages [11]. Functional characterization of Nva-
shA clearly demonstrated that it is necessary and sufficient
to promote expression of the neural marker Nvelav1 and
a number of putative neural subtype markers [11]. Based
on previous work, a reasonable model for Nematostella
neurogenesis is that Notch activity selects Nvath-like +
NvsoxB(2) + neural progenitors from a pool of naïve cells;
daughters of those progenitor cells express additional
neurogenic genes such as NvashA, which in turn promote
expression of post mitotic markers such as Nvelav1 and
neural subtype markers [1]. However, the upstream in-
ductive mechanisms responsible for initiating neurogenic
cascades in Nematostella remain elusive, as do the mo-
lecular programs that give rise to NvashA-independent
neural subtypes during neurogenesis.
FGF, Wnt, BMP, and Mitogen-activated protein kinase
(MAPK) signaling cascades regulate neural induction in
multiple species [12–17]. FGF, Wnt, and MAPK all pro-
mote neural development in other species [12–14, 16],
whereas BMP activity is best known for its role in sup-
pressing neural induction of the forming central nervous
systems of model systems [14, 15, 18]. In Nematostella
the role of these signaling pathways during neural induc-
tion is unclear. Disruption of Wnt signaling does result
in neural phenotypes. However, the phenotypes are at-
tributable to disrupted axial patterning [19–21]. Neural
phenotypes resulting from loss and gain of BMP activity
are complicated in that either manipulation results in
loss of neurons, and neural phenotypes are restricted to
larval stages [22, 23]. FGF-mediated MAPK signaling is
one of many ways to initiate a receptor tyrosine kinase
(RTK) cascade. Investigation of FGF signaling in Nema-
tostella has primarily focused on its role in apical organ
formation, and no broad neural phenotypes are reported,
with the caveat that the current array of neural markers
did not exist at the time of the initial study [24]. To date,
the impact of MAPK signaling on neurogenesis has not
been reported in Nematostella.
RTK signaling cascades are characterized by a series of
kinases that are activated by upstream kinase and in turn
activate a downstream kinase. Near the end of the cas-
cade, activated MEK kinase phosphorylates ERK, which
can translocate to the nucleus to phosphorylate and acti-
vate a number of transcription factors. Multiple RTK
signaling cascades converge on MEK. For example, in
Nematostella, FGF signaling controls apical organ for-
mation at larval stages, and pharmacological inhibition
of MEK is able to phenocopy gene-specific MO-
mediated knockdown of the FGF-receptor NvfgfRa [24].
The number of MAPK-like pathways that could be act-
ing to regulate neural development in Nematostella is
large. There are at least 12 FGF-like ligands and two
FGF receptors in the Nematostella genome [2, 25]. Two
ligands and one receptor (Nvfgfa1, Nvfgfa2, NvfgfRa) are
expressed in the vegetal hemisphere/apical domain, the
ligand Nvfgf8 is expressed in the animal hemisphere and
its descendants, and the receptor NvfgfRb in derivatives
of both poles [24–26]. There are at least 25 additional
receptors (Johnston & Röttinger, unpublished) that
could activate MEK/ERK signaling in Nematostella. Be-
cause the number of possible RTKs is relatively high,
one strategy to better understand how these genes might
be acting to regulate neurogenesis is to inhibit MEK.
Thus, a number of possible signaling pathways can be
simultaneously disrupted to determine if MAPK signal-
ing contributes to neural development.
Here we use U0126, a potent and specific inhibitor of
MEK [27], to test if MAPK signaling plays a role in
neurogenesis, and to determine if we can use this disrup-
tion to identify other putative neural genes in the early
embryo. We show that treatment with U0126 reduces
expression of Nvath-like, NvsoxB(2), NvashA, and post-
mitotic neural markers. Loss of embryonic neurogenesis
following U0126 treatment cannot be rescued by NvashA,
suggesting U0126 treatment desensitizes embryonic cells
from responding to proneural cues. We performed a
genome-wide expression array to identify new MEK
downstream targets, enabling us to characterize 18 novel
salt-and-pepper-expressed genes. We tested the role of
the putative FGF receptor NvfgfRa, which was the most
likely candidate pathway disrupted by U0126 in regards to
neural marker expression. However, we found no evidence
suggesting that NvfgfRa signaling regulates neurogenesis
or any of the salt-and-pepper genes identified in the
U0126 microarray. We also investigated the relationship
of these novel salt-and-pepper genes with NvashA-
dependent neurogenesis. We confirmed one positive and
one negative target of NvashA, Nvvsx-like and Nvath-like
respectively. Lastly, we expanded our study to gain insight
into whether NvashA regulated one or multiple neuronal
subtypes. Using transgenic animals and double fluorescent
mRNA in situ hybridization, we confirmed that NvashA
regulates at least two distinct neural subtypes; however,
based on its expression pattern at later developmental
stages [11], this number is likely much higher. Addition-
ally, the identification of ~80 genes that are expressed in
the presumptive endomesoderm and aboral pole suggests
that MAPK signaling plays a key role in multiple aspects
of Nematostella embryogenesis. Taken together, our data
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and previously published results allow us to incorporate
MEK, a key regulator, in a preliminary gene regulatory
network describing embryonic NvashA-dependent neuro-
genesis, and provided us with a list of additional likely
neurogenic genes, aboral genes, and endomesodermal
genes for future studies.
Results
Determining ideal dose of U0126 to inhibit MEK inhibition
To determine the most effective concentration of U0126
to use for our analyses, we treated fertilized zygotes with
increasing concentrations of U0126 and analyzed expres-
sion of the previously described U0126 target Nvfgfa1 as
well as two markers of the animal hemisphere, Nvspro-
uty and Nvbra [24, 25, 28, 29] (Fig. 1). Nvsprouty was
expressed throughout a central domain at the animal
pole in the presumptive endoderm (Fig. 1a, whereas
Nvbra was expressed in a central ring surrounding the
future endodermal tissue (Fig. 1h). These two additional
markers were chosen because we observed gastrulation
failures in preliminary tests of the U0126 compound on
early embryos and, in bilaterians, expression of sprouty
homologs is downstream of FGF signaling (Fig. 2) [30].
U0126 treatments of 1–10 μM reduced Nvsprouty ex-
pression, but had little to no impact on the expression of
Nvfgfa1 or Nvbra (Fig. 1a–d, g–j, m–p; Additional file 1:
Table S1). However, at a concentration of 15 μM, both
Nvfgfa1 and Nvsprouty were undetectable in U0126-
treated animals (Fig. 1e, q; Additional file 1: Table S1).
Interestingly, treatment with 15 μM U0126 induced ec-
topic Nvbra expression within the endoderm-forming
central domain (Fig. 1k, l), suggesting that MEK signaling
actively represses Nvbra in the most central endoderm-
forming domain. Based on the ectopic expression of
Nvbra in the central domain as well as the complete in-
hibition of Nvsprouty and Nvfgfa1 expression in 15 μM
treatments (Fig. 1e, k, q; Additional file 1: Table S1), we
concluded that 15 μM of U0126 is an effective dose, and it
is unlikely phenotypes are due to toxicity.
Inhibition of MEK prevents ERK phosphorylation and
gastrulation
To ensure U0126 treatment is inhibiting MEK, we
screened embryos treated with either dimethyl sulfoxide
(DMSO) as a control or U0126 for the presence of phos-
phorylated ERK (pERK) (Fig. 2) [31]. pERK staining in
controls was detected at low levels in most cells of the
blastula, but was enriched in the presumptive endoderm
cells that undergo invagination (Fig. 2a). In U0126 treat-
ments, a positive pERK signal above the general ectoder-
mal staining was not detected (Fig. 2f ). We further
analyzed the morphological phenotypes induced by the
Fig. 1 Dose-dependent effects of the MEK inhibitor U0126 on embryonic gene expression. Control blastula stages at 24 hours post fertilization
(a, g, m) and embryos treated with increasing concentrations of U0126 (b–f, h–l, n–r). In situ hybridization on blastula stages using Nvsprouty
(a–f), Nvbrachyury (g–l), or NvfgfA1 (m–r) antisense probes. All images are lateral views with the presumptive endomesoderm (animal pole, future
oral pole) to the top. The insets correspond to animal pole views. Numbers in lower left corner correspond to the number of animals with
phenotype pictured / total number of animals assayed
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disruption of ERK signaling and observed that treated
embryos dramatically failed to gastrulate and form a gut
(Fig. 2g–j) compared to control embryos (Fig. 2b–e).
NvashA, Nvath-like, and NvsoxB(2) are globally
downregulated in U0126-treated embryos
We next tested if U0126 treatment would disrupt ex-
pression of the known neural genes. We treated embryos
with U0126 and scored for expression of known neural
genes NvashA, Nvath-like, and NvsoxB(2) (Fig. 3).
mRNA in situ hybridization on U0126-treated and con-
trol animals during early gastrula stages [24 hours post
fertilization (hpf ) at 17 °C] (Fig. 3) revealed that all three
genes—NvashA, NvsoxB(2), and Nvath-like—were glo-
bally reduced in U0126-treated animals (Fig. 3). How-
ever, they did not all display the same sensitivity to
U0126. Nvath-like expression was undetectable in 82 %
and NvashA expression was undetectable in 96 % of
U0126-treated embryos (Fig. 3A, C). NvsoxB2 expression
was dramatically reduced, both in terms of the number
of cells expressing it and in the level of expression
(Fig. 3B), but expression was detectable in many more
embryos than observed for either NvashA or Nvath-like.
Interestingly, we identified NvsoxB(2) as being mater-
nally expressed using the SeaBase database of transcrip-
tomes (Additional file 2: Figure S1) [32–34]. To address
whether or not U0126 might have a more severe impact
on NvsoxB(2), we treated animals at late gastrula stages
for 24 hours with U0126 or DMSO control. We
observed that NvsoxB(2) expression was not detectable
in 87 % of U0126-treated cells (Additional file 3: Figure
S2A). We also observed a strong reduction in NvashA
expression in animals treated with U0126 for 24 hours
after completion of gastrulation (Additional file 3: Figure
S2B). These data suggest that the earliest known
neurogenic transcription factors are globally reduced
in U0126-treated animals, which indicates that neuro-
genesis is disrupted by U0126.
NvashA misexpression fails to rescue neurogenesis in
U0126-treated animals
To test if U0126 treatment impacted neurogenesis,
treated animals were allowed to develop until a time
equivalent to the late gastrula stage and screened for ex-
pression of the broadly expressed neural marker Nvelav1
and previously identified NvashA neural target genes by
mRNA in situ hybridization. U0126 treatment dramatic-
ally reduced expression of neural markers, such that they
were essentially undetectable (Fig. 4). Two exceptions were
NvLWamide-like (PrtID# 242283, http://genome.jgi.doe.-
gov/Nemve1/Nemve1.home.html) and NvanthoRFamide,
which showed staining in a few cells (Fig. 4A’, 4H’), but both
were reduced compared to control DMSO-treated animals.
We conclude that treatment with U0126 results in a nearly
complete loss of embryonic neural marker expression.
We next aimed to determine if loss of neural markers in
U0126-treated animals could be rescued by misexpression
of neurogenic transcription factors. NvsoxB(2) and Nvath-
Fig. 2 U0126 blocks ERK activation, endomesoderm formation, and gastrulation. a–e Control embryos. f–j U0126-treated embryos. a, f Confocal
z-sections using anti-phospho-ERK (cyan) to visualize activated ERK. The gray dotted lines indicate the outline of the embryo and yellow arrows
the accumulation of phosphorylated ERK (pERK)-positive cells above background levels. b–e, g–j Confocal z-sections using phalloidin (green) to
show f-actin filaments and propidium iodide (red) to visualize the nuclei. a, b, f, g Blastula stages [24 hours post fertilization (hpf)]. c, h Late gastrula
stages (48 hpf). d, i Early planula (72 hpf). e, j Late planula (96 hpf). All images are lateral views with the animal/oral pole to the top. The insets in a and
f correspond to animal pole views. Ratios in g–j indicate the number of embryos displaying the phenotype shown in the image to the total number
of analyzed embryos
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like act upstream of NvashA, both have much broader
roles than NvashA in neurogenesis, and both are
expressed in neural progenitor cells [9, 10]. However, mis-
expression phenotypes are not reported for either of these
genes. We were also concerned that over-activation of
progenitor cell markers could result in a loss of neural
markers due to an inability to transition from an undiffer-
entiated to a differentiated state [35]. Thus, observing no
rescue with misexpression of either NvsoxB(2) or Nvath-
like could represent a false negative neural phenotype.
NvashA is expressed in differentiated cells, and misexpres-
sion of NvashA has already been shown to be sufficient to
induce ectopic neural marker expression [9, 11]. We
injected in vitro transcribed NvashA:venus mRNA and
treated animals with U0126. Surprisingly, we observed no
rescue of the neural markers (Fig. 4A"–H”). To ensure that
NvashA:venus behaves as previously reported [6, 11], we
treated animals injected with NvashA:venus mRNA with
U0126. High levels of NvAshA:Venus were still detectable
and localized to the nucleus (Additional file 4: Figure S3).
We conclude that NvashA is not sufficient to rescue
neural marker expression in U0126-treated animals.
The failure of NvashA to rescue U0126-induced loss of
neurogenesis might be a consequence of the reduced
NvsoxB(2) and Nvath-like expression in U0126-treated
animals. To address this hypotheses we took advantage
of the previous observation that NvashA restores neural
marker expression lost in animals with hyperactivated
Notch signaling even though NvsoxB(2) and Nvath-like
remain strongly downregulated [36]. To compare the
downregulation of NvsoxB(2) and Nvath-like induced by
hyperactivation of Notch to the downregulation ob-
served in U0126-treated animals, we performed mRNA
in situ hybridization experiments in NvnotchICD:venus-
injected animals (Additional file 3: Figure S2). Injection
of NvnotchICD:venus mRNA resulted in 83 % of animals
showing no or weak NvsoxB(2) expression and 88 % of
animals showing no Nvath-like expression (Additional
file 3: Figure S2). Both genes were more severely reduced
in NvnotchICD:venus-injected animals than they had
been in U0126-treated animals (compare Fig. 3A, B to
Additional file 3: Figure S2A, B). Taken together with
previous reports that NvashA rescues neuronal loss
induced by Notch hyperactivity without increasing
NvsoxB(2) or Nvath-like expression, we argue that
U0126 disrupts neurogenesis in two ways. It inhibits the
expression of the neurogenic transcription factors
Nvath-like, NvsoxB(2), and NvashA, and it disrupts a yet
unknown pathway that is also required for NvashA to
promote neural fates.
Fig. 3 U0126 treatment results in a global decrease in neurogenic transcription factors. mRNA in situ expression of Nvath-like (A), NvsoxB(2) (B),
and NvashA (C) in control embryos treated with in 1/3× artificial seawater (ASW) with 0.1 % dimethyl sulfoxide (DMSO). Expression of Nvath-like
(A’), NvsoxB(2) (B’), and NvashA (C’) in animals treated with 15 μm U0126 in 1/3× ASW with 0.1 % DMSO. Embryos were classified and quantified
as the percent having normal expression, weak expression, or no expression. Refer to key in figure for classification of phenotypes. The
phenotypic class with the highest percentage of embryos is indicated. All embryo images are of early gastrula stage. The main figure
panels are ectodermal focal planes of lateral views with the presumptive oral side to the left. The insets show deeper focal planes used
to confirm embryonic stage
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NvashA target genes likely represent multiple distinct
neuronal subtypes
We wanted to confirm that NvashA regulates multiple
neuronal subtypes. Although NvashA is expressed in a
subset of the nervous system, subtle differences in the
expression domains of NvashA targets suggests that they
describe distinct neural subtypes [11]. To test if NvashA
regulates distinct neural subtypes we performed double
fluorescent in situ hybridizations and created stable
meganuclease-mediated transgenic reporters for two of
the NvashA targets using an approximately 2000-base-
pair genomic region immediately upstream of the start
codon for both genes to drive expression of mCherry
fluorescent protein (Fig. 5) [37]. We chose NvLWamide-
like (PrtID# 242283) (Fig. 5a, b) and Nvserum amyloid
A-like (PrtID# 239910) (Fig. 5a, c) because these genes
represent NvashA targets with overlapping but slightly
different expression patterns during development, and
both genes were strongly downregulated in the U0126
microarray (see below; Additional file 5: Table S2,
Additional file 6: Table S3). Both genes were expressed
broadly throughout the aboral region of the embryo, but
the NvLWamide-like expression domain extended more
orally and encompassed a larger domain than that of
Fig. 4 NvashA is insufficient to rescue neuronal loss resulting from U0126 treatment. mRNA in situ expression of each gene is indicated in control
embryos raised in 1/3× artificial seawater (ASW) with 0.1 % dimethyl sulfoxide (DMSO) (A–H), compared to embryos treated with 15 μm U0126 in
1/3× ASW with 0.1 % DMSO (A’–H’), and compared to embryos injected with NvashA:venus mRNA and treated with 15 μm U0126 in 1/3× ASW
with 0.1 % DMSO (A”–H”). Genes are referred to by either name or protein ID number used in the Nematostella genome database v1.0 (http://
genome.jgi.doe.gov/Nemve1/Nemve1.home.html). Embryos were classified and quantified as the percent having normal expression, weak
expression, or no expression. The phenotypic class with the highest percentage of embryos is indicated. Treatment with U0126 strongly reduced
all neural gene expression (compare A’–H’ with A–H). Misexpression of NvashA in U0126-treated animals was not sufficient to rescue neuronal
loss induced by U0126 treatment (compare A”–H” to both A–H and A’–H’). All animals in panels A–G, A’–G’, and A–-G” are aboral ectodermal
focal planes of 48 hours post fertilization embryos (late gastrula stage). Embryos in panels H, H’, and H” are a lateral view with oral side facing
towards the left
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Nvserum amyloid A-like (Fig. 5a) [11]. NvLWamide-like
was expressed in more cells than Nvserum amyloid A-like
(Fig. 5a). Double fluorescent mRNA in situ hybridizations
revealed that many of the Nvserum amyloid A-like ex-
pressing neurons (Fig. 5a, red) were also positive for
NvLWamide-like (Fig. 5a, green). However, there were
many examples of NvLWamide-like-only-positive cells
and few examples of Nvserum amyloid A-like-only-posi-
tive cells (Fig. 5a). Thus, it is likely that there are at least
three molecularly distinct neural subtypes that require
NvashA for development.
We next compared the neurons labeled in each trans-
gene to determine if the neurite projections from
Nvserum amyloid A-like and NvLWamide-like neurons
are similar or distinct. Although there were a number of
neurons with similar neurites that projected along the
oral–aboral axis in each transgene (Fig. 5b, c, yellow
arrows), each transgene also labeled neurons with
distinct morphologies (Fig. 5b, c, white and pink arrows,
respectively). Consistent with the mRNA in situ
hybridization results, the NvLWamide-like::mCherry
labeled more cells than NvSerum Amyloid A-
like::mCherry (compare Fig. 5b and c). Interestingly,
there were distinct cell types present in each line [for
example, NvLWamide-like::mCherry was expressed in
ectodermal cells that had three neurites extending from
the soma (Fig. 5b, white arrow), and NvSerum Amyloid
A-like had unique neurons with neurites that extended
out of either side of the soma and projected orally to
form U-shaped neurons (Fig. 5c, pink arrow)] that could
be reproducibly identified in individual transgenic ani-
mals. Although more extensive characterization is re-
quired for each of these transgenic lines, the fact that
NvashA targets have distinct expression patterns and
that neurons described by the transgenes of two Nva-
shA targets display distinct morphologies support the
conclusion that NvashA regulates multiple neuronal
subtypes.
Fig. 5 NvashA regulates multiple neuronal subtypes. Shown are three-dimensional projections of two juvenile polyps shown with the oral side
towards the top of the image. a Double fluorescent in situ hybridization of NvLWamide-like (red) and Nvserum amyloid A-like (green) in a late
gastrula stage embryo. b The transgenic line for NvLWamide::mcherry expression is shown. Neural soma and neurites are observed throughout the
body column and tentacles. Ectodermal neurons with three projections are observed in the body column (white arrow), which are not
found in the other transgenic line. c The transgenic line for Nvserum amyloid A-like::mcherry is shown. There are many fewer neurons
compared to NvLWamide::mcherry, but characteristic neurons are present. The U-shaped neuron that has two orally projecting neurites
(pink arrow) is specific to this transgenic line. Both lines have neurons that are located just over the mesenteries and send projections orally and
aborally in neural tracts overlaying the mesenteries (yellow arrows). In all images, asterisks indicate relative position of mouth
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Identification of 100 genes downregulated and 22 genes
upregulated by U0126 treatments
To determine if U0126 regulates other potential neuro-
genic genes and to identify novel targets of MEK signal-
ing, we applied a forward molecular approach using a
genome-wide expression microarray. Zygotes were
treated with U0126 or DMSO until late blastula stage.
At that point mRNA was extracted and used to generate
labeled cDNA, which was hybridized to a custom ex-
pression microarray (Nimblegen, Inc.) that represents
24,021 predicted N. vectensis gene models [28]. The
Pearson’s correlation factor between biological replicates
was mediocre (0.69), however, 926 genes were signifi-
cantly (P < 0.05) upregulated and 1176 genes were sig-
nificantly (P < 0.05) downregulated in U0126-treated
embryos (Additional file 6: Table S3). Because our focus
was to identify early embryonic patterning events, we
screened the lists of genes to identify transcription fac-
tors, signaling molecules, and signaling modulators. This
resulted in the identification of 100 genes that were
downregulated and 22 genes that were upregulated by
U0126 (Additional file 7: Table S4; Additional file 8:
Table S5 [2, 7, 9, 11, 19, 24, 26, 28, 38–57]). Out of the
122 selected genes, the vast majority (86/122) possess
strong orthology with members of various families of
transcription factors (i.e., forkhead, pointed, homeodo-
main). Twenty-seven genes potentially encode ligands,
modulators, or receptors of signaling pathways (i.e.,
Wnts), and nine genes show similarities with adhesion
molecules, metalloproteases, or RNA binding proteins
with described developmental functions in bilaterians
(i.e., Ncam, Tolloid, Vasa) (Additional file 6: Table S3).
To distinguish between previously published genes and
newly identified ones, we used the best Blast Hit identifi-
cation followed by “-like”. Thus, with the exception of
Nvhes-like and Nvath-like [9, 51], all gene names con-
taining “-like” designate gene products described for the
first time in this study.
Identification of putative neural genes
Neural genes are predicted to have a salt-and-pepper ex-
pression pattern, and thus determining the expression
pattern of the 122 target genes would identify which
genes exhibit salt-and-pepper expression associated with
neural genes. We performed whole mount in situ hy-
bridizations in the developing embryo at blastula stages
(24 hpf ) and at the end of gastrulation (48 hpf, Fig. 6).
We excluded 16 genes because their expression patterns
are already described at the blastula stage, but we did in-
clude genes whose early expression patterns had not yet
been described (Nvgata, for example [23]). We were able
to obtain clones for 98 of the remaining 106 genes and
synthesized anti-sense probes. All original publications
corresponding to a given gene (sequence identification
and/or gene expression pattern) can be found in
Additional file 7: Table S4 and Additional file 8: Table
S5. Our in situ screen revealed reproducible patterns for
60 of the 98 genes we screened. Patterns could be
grouped into one of three categories: (1) genes expressed
in the animal hemisphere/presumptive endomesoderm
of the blastula (24/98) (Additional file 9: Figure S4); (2)
genes expressed in the vegetal hemisphere/aboral domain
of the blastula (18/98) (Additional file 9: Figure S4); and
(3) genes with the characteristic salt-and-pepper pattern
consistent with being neural genes (18/98) (Fig. 6). We
found no link between genes that are expressed broadly in
the animal and vegetal hemispheres and neurogenesis,
and thus will not discuss these genes further here.
Genes expressed in individual cells throughout the ectoderm
The 18 genes expressed in individual cells of the pre-
sumptive ectoderm at the blastula stage or in ectodermal
body wall at the end of gastrulation were Nvsox2,
Nvpea-like3, Nvcoup-like1 (also called NR-like 12), Nv-
coup-like2 (also called NR-like 13) [55], Nvelav-like,
NvemxLX, Nvhd145, Nvtailless-like, Nvvsx-like, Nvgfi-
like, Nvsox10-like, Nvhes-like3, Nvfoxq2-like3, NvfoxD3-
like, Nvdkk-like3, Nvvegef-like1, Nvhox2, and Nvhd052
(Fig. 6). Eight genes (Nvelav-like, NvemxLX, Nvtailless-
like, Nvgfi-like, Nvdkk3-like3, Nvvegf-like1, and
Nvhox2 and Nvhd052 we did not detect localized expres-
sion prior to the onset of gastrulation (Fig. 6E,F,N,P,Za-
Zd). Six genes (Nvpea3-like, Nvcoup-like1, Nvvsx-like,
Nvsox10-like, Nvhes-like3, and Nvfoxq2-like3) were
expressed in 5–15 cells (Fig. 6B, C, O, Q, R, Y). For four
genes (Nvsox2, Nvcoup-like2, Nvhd145, and NvfoxD3-like),
more than 15 cells were stained throughout the presump-
tive ectoderm at the blastula stage (Fig. 6A, D, M, Z).
At the end of gastrulation, we observed gene expres-
sion for all above-mentioned genes in individual cells
(Fig. 6G–L, S–X, Ze–Zj, Zl). However, the localization
and number of stained cells varied considerably. The
only gene that appeared to be expressed in individual
cells throughout the entire ectoderm (pharyngeal ecto-
derm, oral ectoderm, body wall ectoderm, sub-apical
pole, and apical pole) was Nvhes-like3 (Fig. 6X), which is
reminiscent of a previously reported gene, NvashA
[11, 51]. Nvsox2 and Nvcoup-like1 (Fig. 6G, I) were
also expressed in a salt-and-pepper manner through-
out all ectodermal domains, except the pharyngeal
ectoderm. The largest group of genes (Nvcoup-like2,
Nvelav-like, NvemxLX, Nvhd145, Nvtailless-like, and
Nvvsx-like) was detected in the body wall ectodermal
as well as the sub-apical and apical domains (Fig. 6J,
K, L, S, T, U). Cells expressing NvfoxD3-like and
Nvdkk3-like3 (Fig. 6Zf, Zg) were detected in the oral
and body wall ectoderm as well as the sub-apical pole
domains; however, Nvsox10-like, Nvfoxq2-like3, and
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Nvvegf-like were only detected in the body wall ecto-
derm and sup-apical domain (Fig. 6W, Ze, Zh). The
genes with the most restricted expression domain
were Nvpea3-like, Nvgfi-like, and Nvhox2, which
were expressed in individual cells either within a cir-
cumferential territory (Fig. 6H, V) or in a patch
within the body wall ectoderm (Fig. 6Zi), respect-
ively. The variable expression patterns suggest that
many of these genes are putatively expressed in dis-
tinct subsets of neurons, while a few broadly
expressed genes might play larger roles during neural
development.
Fig. 6 U0126 targets expressed in individual cells throughout the ectoderm. Wild type salt-and-pepper gene expression analysis by in situ hybridization
of genes differentially regulated by U0126 treatments. All animals are either blastula [24 hours post fertilization (hpf) – A–F, M–R, Y-Zd] or gastrula
(48 hpf – G–L, S–X, Ze–Zj) stages. All images are lateral views with the animal pole to the top. The insets correspond to surface views. Antisense
probes used as indicated. Green stars in Zd and Zj indicate that this gene was upregulated under U0126 conditions. All other genes were downregulated
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Temporal gene expression analysis of salt-and-pepper genes
In situ hybridization provides crucial spatial information
about gene expression but cannot be used quantitatively
to determine the presence of maternal transcripts or
zygotic upregulation of a given gene. However, this in-
formation is crucial for the design of functional studies,
to predict potential genetic interactions, and to build
gene regulatory networks [28]. In order to determine the
temporal deployment of putative neural genes during
early embryogenesis, we performed fine-scale quantita-
tive reverse transcription PCR (RT-qPCR) on RNA/
cDNA that was sampled from unfertilized eggs and
every 2–4 h during embryogenesis up to the late gastrula
stage (48 hpf) Additional file 10: Figure S5. We analyzed
21 salt-and-pepper genes identified both in this and in
previous studies, including the known neural genes such
as Nvath-like and NvashA [9, 11]. Five salt-and-pepper
genes (Nvfoxq2-like3, Nvcoup-like2, Nvelav-like, NvpaxA,
and Nvvegf-like1) were detectable in zygotes, indicating
that they are maternal genes (Additional file 11: Figure
S6). However, it is not yet clear what the significance of
these genes is because none of these genes have broad
expression patterns that might indicate a key early role
for them in neurogenesis. The majority of salt-and-
pepper genes, including the known neural regulators
Nvath-like and NvashA, are not components of the ma-
ternally contributed mRNAs, which suggests that the
earliest neural fates are induced in the embryo. As a
group, the salt-and-pepper genes display a similar tem-
poral deployment. The earliest zygotically regulated
genes are Nvath-like (8–10 hpf ), followed by Nvhes3
(10–12 hpf), NvfoxD3, Nvsox10-like (12–14 hpf),
Nvfoxq2-like3, and Nvsox2 (16–18 hpf), and then the
bulk of genes (12/21) are upregulated at either 18–20
hpf (Nvcoup-like1, Nvcoup-like2, Nvgfi-like, Nvhd145,
Nvtailless-like, Nvvsx-like, and Nvelav-like) or 20–24 hpf
(Nvdkk-like3, Nvpea3-like, NvpaxA, Nvgcm, and Nva-
shA). Our temporal analysis demonstrated two key as-
pects. Nvath-like, which is the first neural gene to
respond to treatment with DAPT and is thought to be
the earliest acting neural gene [9], is in fact upregulated
prior to other known neural genes. Second, the salt-and-
pepper genes all showed strong upregulation between 10
and 24 hpf. The upregulation of genes is continuous in
that different genes are upregulated at different times
throughout the 10–24 hpf window. This argues that
once salt-and-pepper gene expression is initiated there
is a steady increase in the expression of distinct salt-
and-pepper genes. Additionally, temporal differences
in expression might reflect a hierarchal organization
for their functions. The later concept is supported by
the observation that Nvath-like (an upstream neural
regulator) is detected much earlier than NvashA,
which is expressed in differentiated neurons [9].
NvFGFRa does not regulate salt-and-pepper gene expression
in the embryo
ERK-mediated FGF signaling can be inhibited by treat-
ment with U0126 in Nematostella [24], and the NvfgfRa
receptor is expressed broadly in the embryonic ecto-
derm, which makes it a likely candidate responsible for
the U0126 neural phenotype and/or responsible for
regulating some of the newly identified salt-and-pepper
genes. We tested if NvfgfRa might have an early neural
phenotype by injecting the previously described NvfgfRa
MO into embryos [24] and scoring for changes in
Nvath-like, NvashA, and the other 19 genes with salt-
and-pepper gene expression identified in the U0126
microarray. qPCR analysis comparing control MO and
NvfgrRa MO revealed that none of the salt-and-pepper
genes responded to changes in NvfgfRa levels (Fig. 7).
These data suggest NvFgfra signaling is not the U0126
target responsible for the loss of salt-and-pepper
expressed genes in the early gastrula. However, there is a
maternal contribution of Nvfgfra signaling genes [24].
To confirm that this FGF signaling was unlikely the
source of the neural phenotype, we allowed morphant
animals to grow to 48 hpf at 17 °C. In parallel, we
allowed wild-type animals to grow until 24 hpf, when
they are approximately at the late blastula/early gastrula
stage. Animals were then treated with U0126 from 24 to
48 hpf. This treatment regimen allows for the maternal
action of FGF components, thus mimicking a potential
flaw in the Nvfgfra morphant approach. qPCR analysis
of NvashA and Nvfgfra (a target of Nvfgfra MO [24])
demonstrated that Nvfgfra MO effectively inhibited
known targets, but not NvashA (Additional file 12:
Figure S7B). We saw similar results with SU5402
treatment (Additional file 12: Figure S7B). However,
U0126 treatment resulted in a strong reduction in all
genes assayed (Additional file 12: Figure S7). These
data argue that FGF signaling is not the source of the
neural phenotype. Thus, although the neural pheno-
type observed in U0126-treated animals is robust, it
is still unclear what signaling pathway(s) targeted by
U0126 regulates salt-and-pepper gene expression in
the embryonic ectoderm.
NvashA regulates a small subset of the salt-and-pepper
genes
We next wondered if NvashA acted to regulate any of
the U0126 target genes. Based on the role of proneural
genes in other animals we hypothesized that NvashA
might act upstream of or suppress expression of subsets
of the salt-and-pepper expressed U0126 targets. NvashA
was knocked down or overexpressed using the previ-
ously described NvashA translation blocking MO and in
vitro synthesized NvashA:venus mRNA [11]. We assayed
U0126 salt-and-pepper target expression by qPCR after
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disruption of NvashA and confirmed any genes that
showed a response to NvashA disruption by mRNA in
situ hybridization (Fig. 8). We included six control genes.
Four negative controls (Nvfgfra, Nvsfrp1/5-like, Nvsix3/6,
and NvotxC) represented broadly expressed regional pat-
terning genes unlikely to respond to changes in NvashA
function [19, 24, 54]. Two positive control genes, NvLWa-
mide-like (PrtID# 242283) and canalicular multispecific
anion transporter (PrtID# 12533), are both confirmed
positive targets of NvashA [11] and were both also down-
regulated in the U0126 array (Additional file 5: Table S2).
We first assayed for positive targets of NvashA. Over-
expression of NvashA increased the expression of Nvvsx-
like, Nvgfi-like, Nvcoup-like1, Nvsox2, and Nvtailless-like
(Fig. 8a, light gray bars). However, Nvvsx-like expression
was weakly upregulated following injection of NvashA:-
venus mRNA (Fig. 8a light grey bars; Fig. 8d), but Nvvsx-
like was the only upregulated gene that decreased after
NvashA knockdown by MO injection (Fig. 8a, dark gray
bars; Fig. 8b). These data argue that NvashA is necessary
and sufficient for the expression of Nvvsx-like
(Fig. 8a–d). NvashA was sufficient but not necessary
to regulate Nvtailless-like in the early gastrula. Over-
expression of NvashA increased the expression of
Nvtailless-like (Fig. 8a, light gray bars). However,
Nvtailless expression was not dependent on NvashA,
as its expression level was not decreased in NvashA
morphants (Fig. 8a, dark gray bars). Nvgfi-like,
Nvcoup-like1, and Nvsox2 also all showed increases in
expression following injection of NvashA mRNA
(Fig. 8a, light gray bars). However, injection of NvashA
MO also resulted in increased expression of all three
genes (Fig. 8a, dark gray bars). Because reciprocal pheno-
types are not observed between mRNA-injected and MO-
injected animals, and both morphant and overexpression
phenotypes were similar, it is unclear if changes in expres-
sion of Nvcoup-like1, Nvsox2, and Nvgfi-like reflect normal
NvashA activity. Thus, we exclude these genes as targets
of NvashA until NvashA mutant analysis can confirm that
they are downstream of NvashA in the early gastrula. We
conclude that Nvvsx-like is a positive target of NvashA.
We next investigated the 10 genes, Nvath-like,
NvemxLx, Nvhes-like3, Nvsox10-like, NvpaxA, Nvgcm,
Nvgfi-like, Nvhd145, Nvcoup-like2, and Nvelav1, that dis-
played changes in expression consistent with being puta-
tive negative targets of NvashA. Nvhd145 and Nvcoup-
like2 expression was reduced in NvashA-overexpressing
animals, but no change in either gene was observed in
NvashA morphants (Fig. 8a; Additional file 4: Figure S3).
These data suggest that although NvashA is sufficient to
suppress Nvhd145 and Nvcoup-like2, it does not likely
regulate these genes during embryonic stages. Nvath-
like, NvemxLx, Nvhes-like3, Nvsox10-like, NvpaxA,
Nvgcm, Nvgfi-like, and Nvelav1 showed increased ex-
pression at early gastrula stages in NvashA morphant
animals (Fig. 8a, light gray bars), which suggests that
they might be negative targets of NvashA. Only Nvath-
like and NvemxLx showed reciprocal changes in expres-
sion in NvashA gain and loss of function (Fig. 8a, dark
gray bars versus light gray bars). We were only able to
confirm the changes in Nvath-like expression by mRNA
in situ hybridization (Fig. 8e–g). In situ hybridizations
with the NvemxLx probe on wild-type embryos often
took >2 weeks to develop, and even then it was only de-
tectable in very few cells and in only a few of the ani-
mals, arguing that it is expressed at low levels and that
mRNA in situ hybridization is not sensitive enough to
verify this gene. Relative expression strength can be
Fig. 7 NvfgfRa does not regulate U0126-dependent salt-and-pepper gene expression. Relative fold change calculated from quantitative polymerase
chain reaction analysis of triplicate injections of the NvfgfRa morpholino (MO) or a control MO is graphed. Broadly expressed genes, Nvsfrp1/5, NvotxC,
and NvfgfRa, are included as controls. The remaining genes are the salt-and-pepper expressed genes identified by the U0126 microarray. The red box
indicates a region (1.5× to −1.5× fold change) that was defined as the cut off for a significant change in expression. Error bars represent standard error
Layden et al. BMC Biology  (2016) 14:61 Page 11 of 19
inferred by the qT value obtained for any given gene
during qPCR analysis. Essentially, qT values above 35
are often associated with genes that are not expressed.
We consistently obtained qT values of 32–33 for
NvemxLx, arguing that it is in fact very weakly
expressed. Although we could not confirm NvemxLx by
mRNA in situ hybridization, it is likely a negative target
of NvashA because it reproducibly showed reciprocal
changes in expression in response to an increase or de-
crease in NvashA function (Fig. 8a). The remaining puta-
tive negative targets did not show reduced expression
levels in NvashA:venus mRNA-injected animals, and
with exception to Nvsox10-like, their increased expres-
sion in NvashA morphant animals could not be con-
firmed by mRNA in situ hybridization (Additional file
13: Figure S8; data not shown). The increased expression
of Nvelav1 in NvashA morphants was somewhat surpris-
ing, because it has already been shown to be a positive
target of NvashA when assayed at later stages [11, 36].
However, NvashA only regulates a subset of Nvelav1-
positive neurons [9–11], and thus we suspect that Nva-
shA does not play a significant, if any, role in Nvelav1
regulation at this early time point. We conclude that
Nvath-like, NvemxLX, and Nvsox10-like are normally
Fig. 8 NvashA regulates a subset of U0126-dependent salt-and-pepper expressed genes. a Relative fold change calculated from quantitative
polymerase chain reaction analysis of triplicate injections of the NvashA morpholino (MO) versus a control MO (dark gray bars), or NvashA:venus-injected
versus control venus-injected animals (light gray bars). Broadly expressed NvfgfRa, Nvsfrp1/5, Nvsix3/6, and NvotxC regional patterning genes
were included as controls. Two positive control genes, 12533 and 242283, are included. The remaining genes are the salt-and-pepper
expressed genes identified by the U0126 microarray. The red box indicates a region between 1.5× and −1.5× fold change that corresponds to an
insignificant change in expression. The reciprocal phenotypes observed in NvashA MO and NvashA:venus mRNA-injected animals for Nvvsx-like (b–d)
and Nvath-like (e–g) were confirmed by mRNA in situ hybridization. Embryos were classified and quantified as the percent having normal expression,
weak expression, or no expression. The phenotypic class with the highest percentage of embryos is indicated. All embryo images are at the early
gastrula stage. All images are ectodermal focal planes of aboral views. Error bars represent standard error
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suppressed by NvashA at embryonic stages, and that
NvashA is sufficient to suppress expression of Nvath-like
and NvemxLX but not Nvsox10-like.
Discussion
Preliminary gene regulatory network and model describing
NvashA-dependent neurogenesis in the embryonic
ectoderm
Based on previous observations and data presented here,
we propose a model for and preliminary gene regulatory
network describing NvashA-dependent neurogenesis in
the early embryonic ectoderm of Nematostella (Fig. 9a,
b). Based on U0126 phenotypes, we hypothesize that
one or more not yet identified kinase signaling cas-
cade(s) acting through MEK provides a global cue that is
necessary for neural fates. It is not yet clear if all cells
are competent to respond to this cue. However, it ap-
pears that the number of competent cells is greater than
the number of cells that become neuralized, because evi-
dence suggests that Notch signaling integrates the global
cue to restrict a subset of cells to become Nvath-like-
and NvsoxB(2)-positive neural progenitor cells (Fig. 9).
Interestingly, we saw no evidence that either Nvnotch or
Nvdelta were affected by U0126 treatment (Additional
file 5: Table S2), which suggests that the refining activity
of Nvnotch is independently controlled. It is not clear
which, if either, transcription factor [Nvath-like or
NvsoxB(2)] is nearer the top of the neural cascade.
NvsoxB(2) is expressed maternally (Additional file 2: Fig-
ure S1), and both genes appear to be upregulated at ap-
proximately the same time in normal development
(Additional file 2: Figure S1; Additional file 10: Figure
S5). However, increased Nvath-like expression accumu-
lates before NvsoxB(2) increases in animals with inhib-
ited Notch activity [9]. Additionally, NvsoxB(2) and
NvashA co-expression can be observed in post-mitotic
cells, whereas Nvath-like and NvashA double-positive cells
are never observed [9]. Post-mitotic neurons do not ap-
pear to express Nvath-like and they lose NvsoxB2 expres-
sion. Lineage-specific pro-differentiation neural markers
such as NvashA are not expressed until post-mitotic
stages. The observation that NvashA suppresses Nvath-
like expression suggests that one of its functions is to in-
hibit neural progenitor identity. This is contrary to re-
ported interactions for Nvath-like and NvashA [9].
However, the previous study assessed phenotypes at later
time points, and thus cannot account for potential pheno-
types arising due to sustained loss of a key neurogenic
gene causing system-wide defects. Here we look closer at
the onset of neurogenesis, which provides less time for
potential nonspecific phenotypes to arise. Certainly
further efforts are needed to clarify this point. Nva-
shA also promotes the expression of distinct individ-
ual neuronal subtype markers. The mechanism by
which subtype markers are regulated is still unclear,
but it is likely that regionally expressed oral–aboral
patterning genes and the temporal window in which
neural progenitors/neurons are born likely contribute
to neural patterning [11, 19, 21].
It is not clear how only a subset of the NvsoxB(2) and
Nvath-like double-positive cells give rise to NvashA-ex-
pressing cells. NvsoxB(2), Nvath-like, and NvashA ex-
pression do not appear to be restricted to a distinct
spatial domain [9, 11, 41]. One hypothesis is that pro-
genitors give rise to different daughter cells with distinct
identities, and that NvashA defines one such identity.
This idea would be consistent with temporal patterning
observed for neural progenitor lineages in Drosophila
[58]. Alternatively, the time and position at which a pro-
genitor is born might determine its identity and sub-
sequently the identity of the neurons it generates [59,
60]. Regardless, functional studies support a much
broader role for the progenitor marker NvsoxB(2), and
suggest that some additional mechanism is acting to re-
strict NvashA expression to a subset of the NvsoxB(2)-
positive progenitors.
Additional putative neural genes identified here
We have identified 18 new genes expressed early (in late
blastula/early gastrula) stages that are candidate neural
regulators or neural subtype markers. The earliest
expressed gene in our temporal analysis was Nvath-like,
which had been previously identified as an early-acting
neurogenic gene. Two genes turned on slightly after
Nvath-like were Nvhes3-like and NvfoxD3-like. Previous
studies suggest that Nvhes3-like is not sufficient to regu-
late neurogenesis at this stage, but it cannot yet be ruled
out as a neural regulator because efficient Nvhes3-like
knockdowns are not yet reported [36]. The next two
genes to be expressed were Nvsox2 and Nvfoxq2-like.
Again, the broad expression of Nvsox2 was similar to
that of NvfoxD3-like and suggests that it may act broadly
to regulate neurogenesis. Nvfoxq2-like genes displayed
limited expression in the aboral region, suggesting their
neurogenic potential is limited to neurons arising from
that domain. The late-onset genes displayed both broad
and restricted expression patterns, suggesting that at
least some of these genes have roles regulating distinct
neural subtypes. This is supported by the inclusion of
NvashA as a late-onset gene. However, it must be noted
that neurogenesis in Nematostella is a continuous
process and late onset alone is not sufficient to suggest
that a gene acts at the later steps in neurogenesis. Re-
gardless, we have identified a number of putative neural
genes, and future work will allow us to both determine
which genes are definitively neural, and where each gene
fits into the regulatory networks describing the earliest
born neural subtypes in Nematostella.
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Fig. 9 Model of NvashA-dependent embryonic neurogenesis. a Model describing NvashA-dependent neurogenesis at early gastrula stage. Boxes
represent indicted cell types. Solid regulatory lines represent published observations, and dashed lines represent likely regulatory interactions.
b Biotapestry diagram of GRN
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Neural induction in Nematostella
MAPK/MEK activity is required for the expression of
key neural progenitor markers, suggesting that it might
be a component of neural induction in Nematostella.
Loss of neurogenesis following treatment with U0126
implies that a positive neurogenic cue is disrupted by
U0126 treatment. It is tempting to speculate that FGF
signaling may be responsible for neural induction, be-
cause FGF is a positive regulator of neural induction
during vertebrate development [15] and MEK activity
has been described to be downstream of FGF signaling in
other systems. However, we report no phenotype when
the broadly expressed NvfgfRa receptor was knocked
down (Fig. 7). However, we still suspect that some MAPK
signaling through MEK is necessary for neurogenesis. α–
phospho-Erk staining was detected throughout the embry-
onic ectoderm, and this staining was reduced in U0126-
treated animals (Fig. 2). Recently, MAPK signaling was
shown to positively promote neurogenesis in salamander
animal cap explants, in part by inhibiting BMP responsive-
ness due to decreased smad1 expression [13]. However,
expression of the putative neural marker Nvgata is not
sensitive to the level of Nvbmp2/4 in Nematostella gas-
trula [23]. Thus, the potential mechanism by which
MAPK/MEK signaling promotes neural fates is not yet
understood in Nematostella.
Possibly multiple neural inductive events during
Nematostella neurogenesis
Multiple observations raise the hypothesis that distinct
mechanisms may be necessary for neurogenesis in differ-
ent spatiotemporal windows in Nematostella. First,
Nvbmp2/4 does not appear to impact neurogenesis at
early embryonic stages, but expression of neural markers
such as Nvelav1 and NvashA are sensitive to the levels
of Nvbmp2/4 and Nvbmp5/8 in planulae [22, 23]. Sec-
ond, NvashA was not detected in U0126-treated em-
bryos at early gastrula stages, but animals that were
allowed to continue developing in the presence of
U0126 begin to show NvashA expression, albeit in very
few cells (Additional file 12: Figure S7). Third, very few
NvLWamide-positive and NvanthoRFamide-positive cells
were able to form in U0126-treated animals, which sug-
gests that a subset of NvLWamide and NvanthoRFamide
neurons may be U0126-independent. The potential for
multiple neural programs acting in Nematostella suggest
that efforts to isolate specific neurons born in unique
spatiotemporal windows as well developing conditional
alleles to investigate later time points in isolation will im-
prove our understanding of neurogenesis in Nematostella.
Patterning genes identified in the UO126 microarray
In addition to the genes with a neural-like expression
pattern, our forward molecular approach identified ~40
genes downstream of MEK that were expressed at the
animal pole, including genes expressed in the presump-
tive endomesoderm and genes expressed at the aboral
pole. These data suggest that MAPK acts broadly in the
embryo to regulate germ layer specification as well as re-
gional identities associated with axial patterning. UO126
treatment has been reported to suppress formation of
the apical tuft at the aboral pole of the larva, likely via
inhibition of NvFGFRa-mediated MAPK signaling [24,
26]. However, early embryonic patterning of the aboral
domain has been largely understudied, and preliminary
data suggest that distinct mechanisms act at early (em-
bryonic) and late (larval) stages of aboral patterning [19].
Additional FGF receptors and ligands are detected in the
oral domain of Nematostella, suggesting that FGF-
mediated MAPK signaling normally regulates U0126 tar-
gets identified that display oral/animal pole expression
[25]. However, targeted gene-specific knockdowns will
be important to further determine exact mechanisms by
which MEK activity impacts aboral and/or germ layer
specification.
Conclusions
Our data indicate MAPK signaling is necessary for
neurogenesis in the embryonic ectoderm of Nematos-
tella. Our work also built upon previous observations to
improve our understanding of the molecular mecha-
nisms underlying cnidarian neurogenesis and described
two transgenes that describe distinct neural subtypes in
Nematostella. Lastly, we identified ~120 signaling mole-
cules and transcription factors that act downstream of
MEK in MAPK signaling. Future characterization of the
genes will provide critical cues about the early pat-
terning mechanisms acting during Nematostella devel-
opment, which will be important to allow improved
understanding about the origin and evolution of
neurogenesis, axial patterning, and endomesoderm
specification.
Methods
Culture and spawning of Nematostella vectensis
Adult Nematostella were cultivated either at the Kewalo
Marine Laboratory/PBRC of the University of Hawaii
(USA), the Whitney Laboratory for Marine Bioscience of
the University of Florida (USA), the Institute for
Research on Cancer and Aging of the University of
Nice-Sophia-Antipolis (FRA), or Lehigh University
(USA) according to the protocol described in [45]. Males
and females were kept in separate glass bowls (250 ml)
in 1/3× seawater (salinity: 12 pp) [5] at 17 °C in the dark
and water was changed weekly. Animals were fed three/
four times a week with pieces of oysters or brine
shrimps. Manipulating the light cycle induced spawning
and oocytes and sperm were collected separately [4].
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The gelatinous mass around the eggs was removed with
4 % L-Cystein in 1/3× seawater before fertilization and
then washed three times with 1/3× seawater. For the
simultaneous development of the embryos, all oocytes
were fertilized in glass dishes at the same time with
0.5 ml of diluted sperm. Fertilized eggs were kept in dark
in filtered 1/3× seawater at 17 °C until the desired stage.
U0126 and SU5402 treatments
The MEK (U0126, Sigma, # U120) and FGF (SU5402,
Sigma, # SML0443) antagonists were dissolved at a stock
concentration of 10 mM in DMSO and added at to 1/3×
filtered seawater to generate final concentrations as indi-
cated. For SU5402, analysis was done at a final concen-
tration of 20 μM, and for U0126 most experiments were
conducted at a final concentration of 15 μM. Unless in-
dicated, embryos were treated with the drug directly
after fertilization and kept in the dark at 17 °C. If
needed, U0126 was replaced every 24 h with fresh solu-
tions to maintain activity. Treatments were compared to
DMSO-treated control embryos. Embryos were fixed for
in situ hybridization and morphological analysis at in-
dicated stages. mRNA of embryos was extracted 24
hpf (late blastula stage) from two distinct biological
replicates for microarray analysis.
RNA extraction, quantitative PCR, and microarray analysis
RNA extraction, qPCR, and microarray analysis were
performed following protocols described in [46]. RNA
for qPCR and microarray analysis was isolated with Tri-
Pure (Roche, #11667157001) or TRIzol (Invitrogen,
#15596-026) according to the manufacturer's instruc-
tions, and genomic contamination removed using
RNase-free DNase (Qiagen, #79254) for 15 min at 37 °C.
The total amount of RNA was quantified with a Nano-
Drop 2000 spectrophotometer (Thermo Scientific) and
the quality analyzed with a Bioanalyzer 2100 (Agilent
Technologies Inc.). To generate cDNA, 1 μg of total
RNA was used with the Advantage RT-PCR kit (Clon-
tech, #639506) for qPCR analysis. For the fine-scale tem-
poral analysis, total RNA was extracted from the
following stages (in hpf ): 0, 2, 4, 6, 8, 10, 12, 14, 16, 18,
20, 24, 28, 32, 40, and 48. qPCR analysis using a Light-
Cycler 480 (Roche) utilizing LightCycler 480 SYBR
Green 1 Master mix (Roche, #04887352001) was carried
out as described previously [11]. Efficiencies for each
gene-specific primer pair was determined using a five-
fold serial dilution series and only primers with an effi-
ciency ranging from 1.8 to 2.15 were used for further
analysis (Additional file 14: Table S6). The housekeeping
genes Nvactin and/or Nvgadph were used to normalize
relative fold changes between control and manipulated
embryos. Each qPCR analysis was repeated on at least
three independent biological replicates and changes were
analyzed using a Student’s t test. Microarray analysis was
conducted by sending 20 μg of total RNA (RIN value
>8) to NimbleGen (Iceland) for further cDNA synthesis,
labeling, and array hybridization. Two replicates were
sent for each control and U0126-treated animals were
sent. The 4-plex microarray (72,000 features) is an
oligonucleotide-based chip version, custom designed and
produced by NimbleGen Systems (Roche). Array data
are available from http://www.ebi.ac.uk/arrayexpress/ex-
periments/E-MTAB-4831/. Gene expression levels were
normalized in the Nimblescan software according to
[47, 48] and fold changes calculated by comparing ex-
pression values from control and treated embryos.
Array results were screened based on the provided
genome annotations assigned to each array spotID. If
no clear blast hit or gene information was assigned to
the prediction gene model from the Joint Genome In-
stitute, we retrieved the genomic sequences from
http://genome.jgi-psf.org/Nemve1/Nemve1.home.html
for the given gene and performed manual BLAST
(BLASTX) searches [49] against the NCBI database to
determine the nature of the predicted gene product.
All sequences from genes of interest have been used
for BLAST analysis to confirm their nature and to
determine previously published genes.
In situ hybridization, pERK, actin, and nuclear staining
Previously described gene sequences were used to sub-
clone into pGemT (Promega, #A3600) from mixed stage
cDNA. All other sequences used in this study were iso-
lated in the course of a microarray analysis. Genome pre-
dictions as well as expressed sequence tag sequence
information were combined to design primers (Additional
file 15: Table S7) that allowed the amplification and clon-
ing of genes between 0.5 kb and 2 kb as described above.
Accession numbers for all analyzed genes in this study
can be found in Additional file 6: Table S3 and Additional
file 7: Table S4. Embryo fixation, probe synthesis, and in
situ hybridization were performed as previously described
[42]. The MegaScript Transcription Kit (Ambion) was
used to synthesize 0.5–2 kb digoxigenin (DIG)-labeled
(Roche, #11573152910) riboprobes. Hybridization of ribo-
probes (1 ng/μl) was carried out at 62 °C in 50 % formam-
ide hybe buffer and visualization of the labeled probe was
performed using NBT/BCIP as a substrate for the alkaline
phosphatase-conjugated anti-DIG antibody (Roche,
#11093274910). To analyze embryonic and larval morph-
ology, we used Biodipy FL Phallacidin (Molecular Probes/
Invitrogen, #B607) and propidium iodide (Sigma, #81845)
to stain f-actin and the cell nuclei respectively as described
previously [61]. To analyze embryonic localization of acti-
vated ERK, we used a monoclonal antibody that recog-
nizes a phosphorylated epitope of the activated form of
ERK [Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204);
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Cell Signaling, # 4370)]. Antibodies were diluted at 1:200
in blocking solution (PBT (Phosphate Buffered Saline +
0.1 % Tween) + 10 % normal goat serum) overnight at 4 °
C. Following six washes in PBT, embryos were incubated
with the secondary antibody (anti-rabbit Ig), and diluted
at 1:250 for at least 4 h to overnight at 4 °C on a
shaking rocker. Phosphate-buffered saline (PBS) was
used for washes between antibodies. Specimens were
mounted in 80 % glycerol.
Imaging
In situ hybridization images were taken on either a Zeiss
AxioScop 2 mounted with an Axiocam camera triggered
by Axiovision software (Carl Zeiss), a Zeiss Axio Imager
A2 mounted with a Canon 6D triggered by Canon pro-
fessional software, or a Nikon NTi using a Nikon DS-
Ri2 color camera and the Elements software (Nikon). All
expression patterns described here have been submitted
to Kahi Kai, a comparative invertebrate gene expression
database [62] hosted at http://www.kahikai.org/
index.php?content=genes. Scoring of treatment pheno-
types was performed on either a Zeiss Z-1 Axio imager
or a Zeiss Axio Imager A2 microscope and confocal im-
aging was conducted on either a Zeiss LSM710 or Zeiss
LSM Exciter microscope running the LSM ZEN software
(Carl Zeiss). Fluorescent images were false-colored. The
fluorescent channels were merged using ImageJ (http://
rsbweb.nih.gov/ij/) and cropped to final size in Photo-
shop Cs6 (Adobe Inc.). Confocal images for Fig. 5 were
processed using Imaris 8.1 (Bitplane).
Microinjection of mRNA and morpholinos
NvashA:venus or venus mRNA was injected into em-
bryos at 150 ng/μl as previously described [6, 11, 36].
Antisense translation blocking MO against Nvfgfra [24]
and NvashA [11] (GeneTools Inc.; Philomath, OR, USA)
and a control MO (5′ AATAAAAAGAATGCCCCCT-
CACCTCT 3′) with no known targets in the predicted
Nematostella genome were injected at 1 mM
concentrations.
Transgenic strain generation
To generate transgenic animals we amplified genomic
DNA from position Scaffold21: 1349994-1347681 for
Nv239910 (serum amyloid A-like) and from Scaffold60:
1049346-1046951 for Nv242283 (NvLWamide-like).
Numbers correspond to genomic positions available in
the Nematostella genome version 1.0 http://genome.jgi.-
doe.gov/Nemve1/Nemve1.home.html. We cloned each
fragment into the pNvT vector in front of the mcherry
coding sequence as previously reported [37]. Animals
were injected as previously reported [37], and stable F1
lines were identified by screening for fluorescence and
outcrossing to wild-type animals.
Additional files
Additional file 1: Table S1. Dose-dependent effects of U0126 on
Nvsprouty, Nvbrachyury, and Nv-fgfA1 expression. Dose-dependent effects
of U0126 analyzed by in situ hybridization. Analyzed U0126 concentration
as indicated in Row 1 and number of embryos with phenotype scored
based on expansion/reduction of the domain of expression as indicated
in the column on the right. (XLS 33 kb)
Additional file 2: Figure S1. Summary of NvsoxB(2) RNA-seq data. Plot
used data obtained from [33] from two duplicate RNA-seq data sets that
generated transcriptomes over the first 19 hpf. Black trace shows average
of two replicates. (JPG 471 kb)
Additional file 3: Figure S2. Changes in NvashA, Nvath-like, and
NvsoxB2 expression following drug treatments or in with increased Notch
activity. mRNA in situ hybridization for NvsoxB(2) (A) and NvashA (B) in
DMSO-treated control animals grown to early planula stages (48 hpf at
22 °C). NvsoxB(2) (A’) and NvashA (B’) expression in same stage animal
treated with U0126 from 24 to 48 hpf or treated with SU5402 from 24 to
48 hpf (B”). mRNA in situ expression of Nvath-like (C) and NvsoxB(2) (D) in
control embryos injected with the venus mRNA. Expression of Nvath-like
(C’) and NvsoxB(2) (D’) in animals injected with NvnotchICD:venus (the
intracellular domain of the Notch receptor), which has been previously
shown to hyperactivate Notch signaling. Embryos were classified and
quantified as the percent having normal expression, weak expression, or
no expression. The phenotypic class with the highest percentage of embryos
is indicated. In C and D, the main figure panels are ectodermal focal planes,
and insets show deeper focal planes used to confirm embryonic stage. All
images are of lateral views with the oral side to the left. (TIF 34682 kb)
Additional file 4: Figure S3. NvAshA:Venus localization in U0126-
treated animals. NvAshA:Venus protein was detected at high levels and
with strong nuclear localization in U0126-treated animals. (TIF 16187 kb)
Additional file 5: Table S2. Array data for NvsoxB(2), Nvnotch, Nvdelta,
and neural genes used for transgenes or controls in qPCR experiments.
(XLSX 38 kb)
Additional file 6: Table S3. Genes with at least a 2-fold change after
U0126 treatments based on our array analysis. (XLSX 3983 kb)
Additional file 7: Table S4. Selection of 22 genes upregulated after
U0126 treatment. Selected genes that were significantly (P < 0.05) at least
2-fold upregulated by U0126 treatments. SpotID was the genome protein
model ID (JGI) used for the array design. The gene name is based on the
best BLAST hit and if available the previously published name(s) is used.
Abbreviations are indicated in the table legend at the bottom. References
are included in the main text. (XLSX 27 kb)
Additional file 8: Table S5. Selection of 100 genes downregulated
after U0126 treatments. Selected genes that were significantly (P < 0.05) at
least 2-fold downregulated by U0126 treatments. SpotID was the genome
protein model ID (JGI) used for the array design. The gene name is based
on the best BLAST hit and if available the previously published name(s) is
used. Color code and abbreviations are indicated in the table legend at the
bottom. References are included in the main text. (XLSX 37 kb)
Additional file 9: Figure S4. Summary of animal hemisphere and
aboral expression genes identified by U0126 array. mRNA in situ patterns
are included in a manuscript currently in preparation. (PDF 39 kb)
Additional file 10: Figure S5. Gene expression analyzed by
quantitative polymerase chain reaction. Salt-and-pepper expressed genes
as represented in Fig. 6. High-density gene expression profiles are
represented by charts for all genes expressed at the blastula stage
[24 hours post fertilization (hpf)] and/or gastrula stage (48 hpf) analyzed
in this study. The y-axis indicates the relative fold change compared to
unfertilized eggs. The x-axis indicates developmental time in hpf. Gene
names as indicated in the top left corner and the Cp value in unfertilized
eggs is indicated in the top right corner of each panel and was used to
determine the presence of maternal transcripts in Fig. 6 (Cp > 34.00). Cp
corresponds to the crossing point, also known as the cycle threshold (Ct)
value. (PDF 599 kb)
Additional file 11: Figure S6. Summary temporal gene expression
analysis. Summarized results of the temporal high density profiling (qPCR)
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used to determine the presence of maternal transcripts and significant
zygotic upregulation of a given gene expressed in individual cells of the
ectoderm. n.d. Not determined. *Genes that have been identified and
their spatial blastula and gastrula expression patterns characterized
elsewhere (see Additional file 6: Table S3, Additional file 7: Table S4 and
Additional file 8: Table S5). (PDF 62 kb)
Additional file 12: Figure S7. NvashA expression in animals with varied
regiments of U0126 treatment. (A) NvashA expression in control animals,
or in animals treated with U0126 continuously for 48 hours, or from 24 to
48 hpf. Unlike early stages when no NvashA expression could be
detected (Fig. 3), NvashA expression was ultimately detected in U0126-
treated animals by 48 hpf. Treatment with U0126 from 24 to 48 hpf
reduced NvashA expression, but NvashA could be detected in many cells,
albeit at reduced levels. (B) Levels of NvashA and Nvfgfa1 as detected by
qPCR at late gastrula stage (48 hpf at 17 °C) in animals injected with the
Nvfgfra MO or treated with U0126 or SU5402 from 24 to 48 hpf. Relative
expression levels are compared to control MO- or DMSO-treated animals
respectively. The red box defines 1.5 to −1.5 fold change region. Error
bars are standard error. (TIF 11166 kb)
Additional file 13: Figure S8. NvashA regulation of target genes in the
embryonic ectoderm. Gene expression in NvashA morphants (A–C),
control morpholino (D–F), and NvashA mRNA injected (G, H).
Quantification below each image represents percent of embryos in each
phenotypic class (see key in figure). All images except C and F are aboral
views. C and F are oral views. Embryos were classified and quantified as
the percent having normal expression, weak expression, or no
expression.. The phenotypic class with the highest percentage of
embryos is indicated. (TIF 21122 kb)
Additional file 14: Table S6. Primer pairs used in this study for qPCR
analysis. (XLS 53 kb)
Additional file 15: Table S7. Primer pairs used in this study for gene
cloning. (XLS 73 kb)
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